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Aedes aegypti mosquitoes carrying the wAlbB Wolbachia strain show a
reduced capacity to transmit dengue virus. wAlbB has been introduced
into wild Ae. aegypti populations in several field sites in Kuala Lumpur,
Malaysia, where it has persisted at high frequency for more than 2 years
and significantly reduced dengue incidence. Although these encouraging
results indicate that wAlbB releases can be an effective dengue control strat-
egy, the long-term success depends on wAlbB maintaining high population
frequencies and virus transmission inhibition, and both could be compro-
mised by Wolbachia–host coevolution in the field. Here, wAlbB-carrying
Ae. aegypti collected from the field 20 months after the cessation of releases
showed no reduction in Wolbachia density or tissue distribution changes
compared to a wAlbB laboratory colony. The wAlbB strain continued to
induce complete unidirectional cytoplasmic incompatibility, showed perfect
maternal transmission under laboratory conditions, and retained its capacity
to inhibit dengue. Additionally, a field-collected wAlbB line was challenged
with Malaysian dengue patient blood, and showed significant blocking
of virus dissemination to the salivary glands. These results indicate that
wAlbB continues to inhibit currently circulating strains of dengue in field
populations of Ae. aegypti, and provides additional support for the
continued scale-up of Wolbachia wAlbB releases for dengue control.
This article is part of the theme issue ‘Novel control strategies for
mosquito-borne diseases’.1. Background
Releases ofAedes aegypti carrying thematernally inherited bacterial endosymbiont
Wolbachia are being trialled in several countries as a novel arbovirus intervention
[1–3]. Certain strains of Wolbachia possess attributes ideal for vector control;
they have a capacity to invade mosquito populations while simultaneously redu-
cing the transmission potential for important arboviruses, including dengue.
The capacity of Wolbachia to spread through a population arises from a mating
incompatibility (commonly known as cytoplasmic incompatibility, CI) between
Wolbachia-carrying males and Wolbachia-free females, which renders the resulting
progeny inviable, whileWolbachia-carrying females are able to reproduce success-




2thewAlbBWolbachia strain have been released in several sites in
Kuala Lumpur, Malaysia, resulting in stable establishment in
some areas. Residents of sites with high wAlbB frequencies
experienced a decline in dengue incidence of approximately
40% compared to controls, although this is likely an underesti-
mate of the true decrease in transmission given the potential for
exposure outside of the release areas [1].
Levels of viral inhibition vary substantially between
Wolbachia strains, ranging fromno inhibition to complete block-
ing [4–6]. Different strains replicate to different levels within a
host, and with a few exceptions, the level of viral blocking
generally shows a positive correlation with Wolbachia intra-
cellular density [6,7]. The distribution of Wolbachia in host
tissues is also important for transmission blocking given
evidence that viral inhibition is cell autonomous [8,9]. To
achieve transmission in a mosquito, an arbovirus present in a
bloodmeal must invade the midgut epithelium, disseminate
in the haemolymph, and eventually establish an infection in
the salivary glands. The presence of Wolbachia in the somatic
tissues of the midgut and salivary glands is, therefore, central
to the transmission-blocking phenotype. The high-density
strains wMelPop and wAu reach very high somatic densities
and generate particularly strong transmission blocking [4,8],
although highWolbachia densities are also associatedwith viru-
lence in the host, negatively affecting a range of life-history
traits including fecundity, longevity and egg survival over
extended periods of quiescence [4,10]. Higher density strains,
therefore, have a lower invasion potential which can limit
their use in field interventions. wMelPop-carrying Ae. aegypti
were released in field sites in Australia and Vietnam and
despite reaching high initial frequencies, the strain was lost
once releases ceased [11].wAlbB reaches intermediate densities
in Ae. aegypti and has a relatively low impact on many aspects
of host fitness [4,12], while providing significant inhibition of
dengue transmission [4,13,14].
Avariety of environmental and symbiont/host genetic fac-
tors influence the density and tissue distribution of Wolbachia.
High larval breeding site temperatures, for example, cause dra-
matic reductions in the density of some strains [4,15,16],
although wAlbB appears to be relatively heat stable [4,16].
Host factors are important in restricting Wolbachia tropism to
the germline in native associations; wAlbB is largely restricted
to the germline in its native host Aedes albopictus [17], whereas
wAlbB in Ae. aegypti has a broad somatic distribution [4].
Interestingly, transfer of the wMel strain (native to Drosophila
melanogaster) into Ae. albopictus results in high densities in
midgut and salivary gland tissue [17] and strong viral inhi-
bition [18]; thus restricted tissue tropism within a particular
host species can be Wolbachia strain-specific. In addition to
inter-species variation, intra-species differences may also play
an important role. Experimental evolution of wMel-carrying
Ae. aegypti generated differences in virus inhibition among
wMel-carrying lineages which correlated with genetic changes
in the host genome, although thiswas independent ofWolbachia
density [19].
As with any vector control method, evolutionary responses
have the potential to disrupt the long-term stability of a
Wolbachia-based intervention. Since Wolbachia is maternally
transmitted, the symbiosis is expected to evolve towards a
more benign or even mutualistic association through adap-
tations of the host, the symbiont or both [20]. Given that virus
transmissionblocking is largelygovernedbyWolbachiadensities
in somatic tissues, and that high titre somatic Wolbachia can bevirulent, natural selection may act to decrease densities in the
midgut and salivary glands, leading to a reduction in overall
viral inhibition. However, an eventual loss of viral inhibition is
not necessarily the default evolutionary outcome. Virus inhi-
bition may even be selected for; a recent study reported that a
lineage of wMel-carrying Ae. aegypti that exhibited lower virus
inhibition also had reduced relative fitness [19]. Importantly,
the authors of this studymanaged to select for lower virus inhi-
bition from field-collected mosquitoes through experimental
evolution, while failing to select for stronger inhibition, indicat-
ing that lineageswith strong inhibition persist at high frequency
in the field. Furthermore, Wolbachia-mediated resistance to
pathogenic insect-specific viruses may act as a source of selec-
tion to maintain the virus inhibition phenotype, although
the magnitude of this selective pressure remains to be deter-
mined in wild mosquito populations. Consistent with a lack
of strong selection on Wolbachia or host, the wMel strain has
maintained both virus inhibition and deleterious fitness traits
in Australian populations of Ae. aegypti nearly a decade after
introduction [21,22].
Given the potential for host genotype effects on viral inhi-
bition, and the possibility of host and symbiont evolution,
long-termmonitoring of field populations for phenotypic stab-
ility forms an important part of the routine surveillance of a
Wolbachia intervention. The wAlbB-carrying Ae. aegypti strain
used in field releases in Malaysia was originally transferred
into an Ae. aegypti colony isolated from wild-caught mosqui-
toes in Kuala Lumpur in the 1960s, and showed complete CI
induction, 100% maternal transmission and inhibition of
dengue transmission [4]. After backcrossing to field-collected
males to improve field performance particularly within the
context of pesticide resistance, the wAlbB strain was released
in a number of sites in urbanKuala Lumpur, includingMentari
Court (a set of seven 18-floor apartment buildings), and Shah
Alam (§7) a commercial/residential zone. Releases in Mentari
Court ceased on the 5 March 2018, with wAlbB spreading
rapidly and maintaining greater than 90% frequency 2 years
later [1]. Releases in Shah Alam ceased on 20 April 2019,
with wAlbB maintaining a frequency of greater than 84%
more than a year later. Given the far greater genetic diversity
of wild compared to laboratory populations, and a higher
degree of mating competition and selection on mosquito fit-
ness in the field, there may be faster evolution towards lower
wAlbB densities in the field versus the laboratory. To assess
whether the field population has undergone an accelerated
rate of selection on density we examined a colony of wAlbB-
carrying Ae. aegypti recently established from mosquitoes
collected in Mentari Court, 20 months post cessation of field
releases.Wolbachia density and tissue distribution, the stability
of the DENV-2 dengue blocking phenotype, CI and maternal
transmission rates are assessed and compared to a laboratory
wAlbB colony. In addition to evaluating the post-release
phenotypic stability of wAlbB, the competence of a wAlbB
field strain established from the Shah Alam release site was
evaluated through oral challenge with DENV-1 infected
blood from a Malaysian dengue patient.2. Results
(a) Wolbachia density and tissue distribution
The densities of Wolbachia in whole adult females reared from


















Figure 1. Wolbachia density in whole adult females. Wolbachia density was
determined at 5 and 10 days post adult eclosion by qPCR. Twenty-four
females were analysed per group. Individual dots represent Wolbachia den-
sities in individual females. A significant difference was found between
wAlbB.MC and wAlbB.L densities at day 5 ( pairwise t-test, p < 0.0001),
although no difference was found at day 10 ( p = 0.17). Boxplots show





from the Mentari Court release site in Kuala Lumpur (hereon
wAlbB.MC) were measured at 5 and 10 days post-eclosion
(PE) and compared to densities in the laboratory wAlbB
colony (hereon wAlbB.L). wAlbB density increased with age
in both mosquito lines (figure 1). The whole-body Wolbachia
density in the wAlbB.MC line was found to be significantly
higher than that in thewAlbB.L line at day-5 PE, although den-
sities between the lines at day-10 PE were similar.
Densities were also measured in the dissected ovary,
midgut and salivary gland tissues from F4 females. wAlbB
density in the ovaries was stable over time and between mos-
quito lines with no statistical differences between the groups
(figure 2a). In midguts, densities differed between ages and
mosquito lines (figure 2b). While at day-5 PE, there was no
difference in midgut wAlbB levels between the two lines, at
day-10 PE the Wolbachia density was significantly higher in
the wAlbB.MC line compared to wAlbB.L. Wolbachia density
in salivary glands was similar between mosquito lines at all
ages (figure 2c).(b) Maternal transmission and cytoplasmic
incompatibility
Rates of Wolbachia maternal transmission in the wAlbB.MC line
were assessed in the progeny of crosses between wild-type (Wol-
bachia-free) males and wAlbB.MC females (i.e. in the absence of
CI). All theG1 offspringwere found to carrywAlbBout of 48 pro-
genyassessedat the larval stage, indicatinghigh rates ofmaternal
transmission (binomial confidence intervals, 92.6–100%).
Reciprocal crosses between the wAlbB.MC line and the
Wolbachia-free wild-type line indicated the retention of full
uni-directional CI, with no eggs hatching from crosses bet-
ween wAlbB.MC males and wild-type females (table 1). No
significant difference in hatch rate was observed between
wAlbB.MC males and females, and wild-type males and
wAlbB.MC females, indicating no loss in capacity to rescue CI.(c) Dengue inhibition
To determine the dengue inhibition capacity of the wAlbB.MC
line, females from the wAlbB.MC and wAlbB.L lines, and a
Wolbachia-free wild-type strain recently established from
field-caught mosquitoes from Kuala Lumpur were orally
challenged with a DENV-2-spiked bloodmeal. Viral load in
dissected salivary gland tissues was assessed by qRT-PCR
12 days post-challenge. Both the wAlbB.MC and wAlbB.L
lines showed a large and significant reduction in the levels of
virus in salivary glands compared to the wild-type control
(figure 3). Although the wAlbB.MC line showed a lower
mean viral load than the wAlbB.L line, the difference between
the wAlbB-carrying lines was not statistically significant.
A second wAlbB-carrying field-derived line was estab-
lished from mosquito larvae collected at the Shah Alam
release site in Kuala Lumpur (hereon wAlbB.SA). To assess
the capacity of wAlbB to block isolates of dengue virus cur-
rently circulating in Malaysia, females from the wAlbB.SA,
wAlbB.L and wild-type lines were challenged with blood
from DENV-1 infected patients. Individual female mosquitoes
were dissected at 7 and 9 days post oral challenge, andmidgut
and salivary gland tissues were assessed for the abundance of
viral RNA. Statistically significant reductions in the levels
of DENV-1 RNA were detected in both the midgut and
salivary gland tissues of both the wAlbB.SA and wAlbB.L
lines relative to the Wolbachia-uninfected wild-type strain
(figure 4). No significant differences in Wolbachia density
were observed between the dengue challenged adults from
the wAlbB.SA and wAlbB.L lines (electronic supplementary
material, figure S1).3. Discussion
wAlbB-carrying Ae. aegypti collected from a field site in Kuala
Lumpur 20 months following the cessation of releases [1] did
not show significant reductions in overall Wolbachia density
or a diminished somatic density and tissue distribution com-
pared to a laboratory colony [4], suggesting an absence of
strong selection in the field. In fact, densities were found to
be higher in the field line in whole bodies and midgut tissues
for some time points. Further work will be needed to deter-
mine whether this difference is maintained with broader
sampling and whether it is driven by host and/or symbiont
genetic factors, or other variables such as the microbiota.
Importantly, wAlbB in the field line continues to effectively
inhibit the capacity for dengue virus to disseminate to and
infect the salivary glands of females, thereby reducing trans-
mission potential, with levels of viral inhibition similar to
those observed in the laboratory wAlbB line and comparable
to that observed in similar challenges performed in the ances-
tral line soon after generation [4]. Additionally, a wAlbB-
carrying field-derived line strongly inhibited dissemination
of dengue virus to the salivary glands when challenged
with clinical isolates of DENV-1 infected blood recently col-
lected from a hospitalized patient in Kuala Lumpur. These
results indicate at least a medium-term stability of wAlbB den-
sity and dengue blocking in field populations of Ae. aegypti.
The results from the clinical blood challenges are particularly
encouraging given that estimates of virus blocking are often
lower when patient blood is used compared to laboratory-
prepared viremic bloodmeals [23,24], and that the clinical
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Figure 2. Wolbachia density in dissected tissues across mosquito lines and ages. Ovaries, midguts and salivary glands were dissected at days 5 and 10 post adult
eclosion, and wAlbB density was determined by qPCR. Each of the five dots represents the Wolbachia density from pools of tissue from three individual female
mosquitoes. No significant differences were observed in ovary density (line effect: F1,16 = 0.97, p = 0.33; age effect: F1,16 = 0.02, p = 0.89; line-by-age interaction:
F1,16 = 0.55, p = 0.47) or salivary gland density (line effect: F1,16 = 0.004, p = 0.95; age effect: F1,16 = 3.39, p = 0.08; line-by-age interaction: F1,16 = 0.002,
p = 0.96). A significantly higher Wolbachia density was observed in the midguts of the wAlbB.MC line at day 10 (line effect: F1,16 = 26.77, p < 0.0001; age
effect: F1,16 = 14.45, p = 0.0016; line-by-age interaction: F1,16 = 14.96, p = 0.0014), but not at day 5 (pairwise t-test, p = 0.6). Boxplots show median and



















Figure 3. DENV-2 inhibition in wAlbB-carrying Ae. aegypti lines. Females
from the wAlbB.MC, wAlbB.L and wild-type lines were fed a bloodmeal
spiked with DENV-2. After an incubation period of 12 days, salivary glands
were dissected and the viral load was quantified by RT-qPCR. Ten, 20 and
27 females were analysed for the wild-type, wAlbB.L and wAlbB.MC
groups, respectively. Black dots indicate salivary glands from individual mos-
quitoes. Red lines indicate median values. wAlbB.MC and wAlbB.L showed a
significant reduction in viral titres ( p < 0.004 for both comparisons, one-way
ANOVA with Dunnett’s). There was no difference in viral load between the
wAlbB.MC and wAlbB.L lines ( p = 0.88, one-way ANOVA with Dunnett’s).
Table 1. Hatch rates from reciprocal crosses between wAlbB.MC and wild-
type Ae. aegypti. Percentages represent egg hatch rates and the total
number of eggs assessed is shown in parentheses. No difference in hatch
rate was observed between crosses of wAlbB.MC males and females, and
wild-type males and wAlbB.MC females ( p > 0.8, Fisher’s Exact test).
male
wild type wAlbB.MC
female wild type 67% (311) 0% (181)





previously shown lower susceptibility to Wolbachia-mediated
inhibition relative to other serotypes [13,24].
As high Wolbachia densities in somatic tissues are
correlated with reduced fitness, selection may be expected
to favour the evolution of genetic factors capable of limiting
symbiont tropism to those tissues essential for maternal
transmission and CI, i.e. the germline. While somatic
Wolbachia do occur in many co-evolved native Wolbachia–
host combinations [25], in some native associations, such as
those found in Ae. albopictus [17] and Glossina morsitans
[26], Wolbachia is largely restricted to the ovaries and testes
of the host. Somatic tissue distribution following transfer
into Ae. aegypti tends to be broad, with particularly high den-
sities in salivary gland tissues [4]. The rate of evolution of
host or Wolbachia factors that limit somatic densities is likely
to depend on the fitness costs associated with the symbiosis,
with higher costs resulting in stronger and more rapid selec-
tion for restricted tropism. Artificial transfer of the virulent
wMelPop Wolbachia strain to Drosophila simulans, for example,
resulted in high initial fitness costs through reductions in
fecundity and egg hatch rates, which were partially attenu-
ated after several generations [27]. This was accompanied
by reductions in density, and suggests rapid selection for
host and/or symbiont genotypes capable of suppressing
Wolbachia over-replication. By contrast, however, severe fit-
ness costs caused by wMelPop have persisted for over a
decade in a transinfected line of Ae. aegypti, suggestingstability of the deleterious phenotypes in this species [28].
Densities of wAlbB in the Malaysian field population were
found to be similar to those of the laboratory colony
20 months after introduction, with densities remaining high
in the somatic tissues of the midgut and salivary glands.
Similar to measurements made in the ancestral wAlbB line
performed shortly after strain generation [4], Wolbachia den-
sities in the salivary glands of the field wAlbB population
were several-fold those in the ovaries. Although wAlbB
does cause a small reduction in adult longevity in labora-


























Figure 4. DENV-1 inhibition in wAlbB lines challenged with patient-derived blood. Females from the wAlbB.SA, wAlbB.L and wild-type lines were fed on clinical
isolates of DENV-1 infected patient blood. After incubation periods of 7 and 9 days, midgut and salivary gland tissues were dissected, and the viral load was
quantified by RT-qPCR. For midguts, tissues from 7, 18 and 13 females were analysed at day 7, and tissues from 7, 15 and 9 females were analysed at day
9 for the wAlbB.SA, wAlbB.L and wild-type groups, respectively. For salivary glands, tissues from 7, 16 and 13 females were analysed at day 7, and tissues
from 6, 14 and 9 females were analysed at day 9 for the wAlbB.SA, wAlbB.L and wild-type groups, respectively. Black dots indicate tissues from individual
mosquitoes. Red lines indicate median values. For midgut tissue, viral RNA titres in wAlbB.SA and wAlbB.L were significantly different from wild-type at
day 7 ( p < 0.004 for both wAlbB.SA and wAlbB.L, one-way ANOVA with Dunnett’s) and at day 9 ( p < 0.002 for wAlbB.SA wAlbB.L, one-way ANOVA with Dunnett’s).
Similarly, for salivary gland tissue, viral RNA titres in wAlbB.SA and wAlbB.L were significantly different from wild-type at day 7 ( p < 0.0001 for both wAlbB.SA and





populations is uncertain given the average lifespan of wild
mosquitoes is expected to be much shorter [29]. Furthermore,
selection for reduced wMelPop densities in D. simulans may
be particularly rapid as it is a native Wolbachia host; existing
host factors capable of suppressing native strains may be
active against novel associations, although these factors
may require some adaptative optimization against divergent
Wolbachia strains. When wAlbB was transferred into Culex
quinquefasciatus, for example, it showed a limited somatic
tissue distribution similar to the native wPip strain—with
which it is closely related—while the more distantly related
wAlbA strain which was also transferred reached high
somatic densities [30]. The low fitness costs associated with
wAlbB and the absence of native Wolbachia in Ae. aegypti
suggests that restrictive host-factor evolution with this sym-
biont/host combination may be slow, perhaps requiring
much longer evolutionary timescales than are relevant in
the context of dengue control programmes.
The wAlbB strain was successfully established in several
sites in urban Kuala Lumpur in 2018, and has maintained
high frequencies since [1]. However, the persistence of wAlbB
in wild Ae. aegypti populations is contingent on the mainten-
ance of high rates of maternal transmission and CI given that
this strain has some fitness costs [31]. The wAlbB maternal
transmission ratewas complete in the field line, and ovary den-
sities were comparable to those found in the laboratory colony.
Maintenance of high ovary density is consistentwith evolution-
ary expectations, as infected females with reduced ovary
densities and imperfect maternal transmission would suffer fit-
ness costs in areas of high Wolbachia frequency resulting from
mating incompatibility with Wolbachia-carrying males.
The wAlbB field line also displayed maintenance of full CI
induction and rescue capacity. Evolutionary models predictthat the stability of the CI phenotype may be compromised
over time by the evolution and spread of host CI repressors
[20,32,33]. Modelling suggests that CI repressors will arise dis-
proportionately in males [20,33], driven by the fitness benefits
of Wolbachia-carrying male compatibility with Wolbachia-free
females. The existence of host CI repressors is supported by
the lack of strong CI in some native Wolbachia/host associ-
ations, where the native host becomes fully susceptible to CI
upon artificial transfer of a new symbiont strain, or conversely
when the native strain induces stronger CI in a non-native host,
as observed in several studies in Drosophila species [34–36].
Evolutionary models also predict that the symbiont genes
underlying the CI phenotype will tend to lose function over
time due to a lack of selection on CI levels [21,32]. Consistent
with this, the recently identified CI genes often carry loss-of-
function mutations [37–40]. However, the persistence of
strong CI in many native associations (including in the mos-
quito species Ae. albopictus and C. quinquefasciatus), strongly
suggests that loss of CI tends to occur over much longer evol-
utionary timescales, and would, therefore, be highly unlikely
to impact on a vector control intervention.4. Conclusion
There is more variability in Wolbachia density in wild
mosquitoes than in laboratory colonies [1], associated with
environmental variability in larval conditions including, for
example, exposure to environmental antibiotics that can
reduce Wolbachia density [41]. Thus, perfect maternal trans-
mission and CI may not be maintained in wild mosquitoes;
direct monitoring of field populations for phenotypic stability
will be an ongoing component of the Wolbachia intervention.
royalsocietypublishing
6The data presented here indicate, however, that wAlbB tested
in the laboratory has not been attenuated in its invasion, popu-
lation maintenance and dengue inhibition capacities following
its presence for 20 months in a field Ae. aegypti population.
These data support the sustainability of interventions using
wAlbB to control dengue transmission. Long-term monitoring
across diverse release sites will be required to fully evaluate the
potential for Wolbachia to reduce the global burden of dengue. .org/journal/rstb
Phil.Trans.R.Soc.B
376:201908095. Methods
(a) Mosquito strains and rearing
Two Wolbachia wAlbB-carrying Ae. aegypti lines were used in
this study. The first is the original wAlbB-carrying line, wAlbB.L
(Lab), generated as previously described [4] and maintained
in controlled laboratory settings for approximately 5 years.
A second line, named wAlbB.MC, was derived from field-
collected eggs from a release area (Mentari Court, 3°04’55.200N
101°36’39.300E) in Kuala Lumpur, Malaysia, in December 2019. As
previously described [1], releases ofWolbachia-carrying mosquitoes
for vector control started in this area in October 2017 and ceased in
March 2018. Ovitraps (plastic containers, 96 mm height, 67 mm
diameter) with 150 ml water and a wooden ovipositor, were
placed in apartment buildings in Mentari Court for a week. Eggs
fromseveral ovitrapswerehatched in the laboratories of the Institute
ofMedical Research inKuala Lumpur (KL); the obtained adults (F0)
were morphologically identified and Ae. aegyptiwere reared in lab-
oratory settings as previously described [1]. Progeny were sent as
eggs to the Centre for Virus Research in Glasgow, UK. Mosquitoes
used in this study ranged from F2 and F4. The wild-type Ae. aegypti
were colonized from Wolbachia-negative mosquitoes collected in
control areas ofKL in February 2018andmaintained in the insectary
of the Centre for Virus Research in Glasgow, UK, for more than 15
generations. Wolbachia status was confirmed in wild-type and
wAlbB-carrying mosquitoes by PCR. Mosquito lines were main-
tained at standard insectary conditions: 27°C and 70% relative
humiditywith a 12-h light/dark cycle. Larvaewere fedwith tropical
fish pellets (Tetramin, Tetra, Melle, Germany) and adults main-
tained with 5% sucrose solution ad libitum. Blood meals were
provided by an artificial blood-feeding system (Hemotek, UK)
using human blood (Scottish National Blood Transfusion Service,
UK). Eggs were collected on a wet filter paper (Grade 1 filter
paper, Whatman plc, GE Healthcare, UK), desiccated for 5 days
and hatched in deionized water containing 1 g l−1 bovine liver
powder (MP Biomedicals, Santa Ana, California, USA).
(b) Wolbachia density in the wAlbB.MC and
wAlbB.L lines
ThewAlbB frequency in thewAlbB.MC line was found to be 100%
in 48 screened individuals from the F2 generation and was
measured by quantitative PCR (qPCR) as described below.Wolba-
chia density between wAlbB-carrying strains was compared 5 and
10 days PE. Whole-body gDNA was extracted from 24 females
from the F3 using STE buffer (10 µM Tris HCL pH 8, 100 mm
NaCl, 1 mmEDTA)with a 95°Cdenaturation for 10 min.Addition-
ally, ovaries, salivary glands and midguts (five pools of three
organs per replicate) were also dissected from 5-day- and 10-day-
old F4 females using sterile forceps and needles in a drop of sterile
PBS buffer, and immediately transferred in STE buffer for DNA
extraction. qPCR analysiswas performed using the relative quanti-
fication of the Wolbachia 16S ribosomal gene (16S_qPCR_F:
GAAAGCCTGATCCAGCCATG/16S_qPCR_R: CGGAGTTAGC-
CAGGACTTCT), against the homothorax gene (HTH) as the
reference gene [40]. 2 × SYBR-Greenmastermix (Biotool, Houston,
Texas, USA)with a BioRadCFX-96 real-time PCRdetection system(Bio Rad, Hercules, California, USA) were used for the amplifica-
tion reaction. The reaction was 95 °C for 5 min, 40× cycles of 95°C
for 15 s and 60°C for 30 s, followed by a melt-curve analysis.
(c) Maternal transmission and cytoplasmic
incompatibility
Rates of CI were assessed by performing reciprocal crosses between
the wild-type and wAlbB.MC lines using 25 virgin females and
males in each cross. Mosquitoes were allowed to mate for 3–5 days
before blood-feeding. Eggs were desiccated for 5 days at standard
insectary conditions (27°C and 70% relative humidity), counted
and hatched in water containing 1 g l−1 bovine liver powder.
Larvae were counted at the L2–L3 stage, and the hatch rate percen-
tagewasmeasured.Toassesswhether the recaptured lineconserved
the complete maternal transmission demonstrated in the original
line [4], 48 individual progeny resulting from the cross between
wAlbB.MC females and wild-type males were tested at the larval
stage forWolbachia using qPCR as described above.
(d) Dengue challenges with blood spiked with DENV-2
Susceptibility to DENV-2 dengue virus was assessed using the
New Guinea C Strain (Public Health England). The virus was
propagated in Ae. albopictus C6/36 cells, the supernatant was
harvested, concentrated using Amicon Ultra-15 filters (Millipore,
IRL) and titrated with fluorescent focus assay (FFA). The primary
antibody for DENV was MAB8705 anti-dengue virus complex
antibody (Millipore); the secondary antibody was the Goat
anti-mouse Alexa Fluor 488, A-11001 (Thermo Scientific,
Waltham, Massachusetts, USA). Fluorescent foci were counted
by eye (from dilutions with less than 100 foci) and virus titres
calculated and expressed as FFU ml−1.
Seven-day-old females were offered an infectious bloodmeal
consisting of human blood and virus suspension (1.4 ×
108 FFUml−1). Engorged females were selected, transferred in con-
tainers in a climatic chamber and maintained at 27°C, 70% relative
humidity, 12-h light/dark cycle with 5% sugar solution. After 12
days, salivary glands were dissected in sterile PBS and scored for
DENV infection using RT-qPCR. RNA was extracted with Trizol
(Thermo Fisher) and diluted to 100 ng µl−1. cDNAwas synthesized
withHighCapacity cDNAreverse transcriptionkit (ThermoFisher).
Virus copies were quantified using primers amplifying the viral
gene NS5 (NS-5-F: ACAAGTCGAACAACCTGGTCCAT/NS5-R:
GCCGCACCATTGGTCTTCTC), and Ct values normalized to the
RpS17 mosquito gene (RpS17 F: CACTCCCAGGTCCGTGGTAT/
RpS17 R: CACTCCCAGGTCCGTGGTAT).
(e) Collection of dengue patient blood
Blood fromadenguepatientwas obtained from theGeneralHospital
Kuala Lumpur, Malaysia. Arrangements were made with the medi-
cal officer (MO) in charge of the dengue ward prior to collecting
blood. The blood was collected on the same day as feeding. The
MO in charge recruited the best candidate based on the pre-set
inclusion and exclusion criteria (for information sheet and consent
form, see electronic supplementary material, file 1). The patient
was initially briefed about the project and the reason for drawing
the blood. The patient had complete freedom to give or withdraw
consent for the use of their blood. Upon receiving consent, 5 ml of
blood was withdrawn and placed in EDTA tubes. Blood was kept
on ice at all times and used in feeding experiments on the same day.
( f ) Dengue challenges with patient blood infected with
DENV-1
The experimental oral infection was conducted within an arthro-




7membrane was used in conjunction with a Hemotek Feeding
System (Accrington, UK) housed in an isolation glove box. Of
dengue patient blood, 1.5 ml was introduced into each feeder.
A total of 150 adult female mosquitoes from each group were
used in the feeding experiment. Mosquitoes were 3–5 days old
and were starved (of sugar solution) overnight. Mosquitoes
were allowed to feed for approximately 30 min. The mosquitoes
were placed at −20°C for 30 s to allow sorting. Unfed mosquitoes
were discarded. Engorged mosquitoes were maintained at 27°C
with a relative humidity of 80% (±10%). At each time-point
(days 7 and 9), a subset of the living mosquitoes was dissected,
with the isolation of midguts and salivary glands. The remaining
carcasses were stored. Individual organs and carcasses were
kept in tubes containing 100 µl MEM media. Samples were
stored at −20°C prior to nucleic acid extraction.
(g) Nucleic acid extraction and quantitative PCR from
patient blood and mosquitoes challenged with
DENV-1
Total nucleic acids were extracted from dissected organs using
an innuPREP DNA/RNA Mini Kit (Analytik Jena AG, Jena,
Germany), enabling the isolation of bothRNAandDNA for quanti-
ficationofDENVandWolbachia, respectively.TheDENVstrain from
patient blood was initially confirmed using real-time reverse tran-
scription PCR (RT-PCR) with DENV 1–4 primer sets [42]. For each
run, multiplex reactions were prepared by combining primer/
probes for DENV1 + 3 or DENV2 + 4 in a single run. The PCRmix-
ture contained 2 µl of extracted RNA, 5 µl of SensiFAST Probe
No-ROX One Step Mix (Bioline, Taunton, MA), 0.4 µl of respective
primer combinations (DENV1+ 3 and/or DENV2 + 4) (400 nM),
0.1 µl of the respective probe (400 nM), 0.1 µl reverse transcriptase,
0.2 µl RiboSafe RNase inhibitor and 1.8 µl of nuclease-free water.
A RT-PCR was performed using the following programme: 45°C
for 10 min, initial denaturation at 95°C for 2 min, followed by 40
cycles with 95°C for 5 s, and 60°C for 10 s. A DENV-1 specific
primer set (DENV-1-F: ATCCATGCCCAYCACCAAT/DENV-1-R:
GTGGGTTTTGTCCTCCATC/DENV-1-Probe FAM-TCAGTGTG-
GAATAGGGTTTGGATAGAGGAA-IowaBlackFQ)was used and
Ct values were normalized to the RpS17 mosquito gene (RpS17-F:CACTCCCA GGTCCGTGGTAT/RpS17-R: GGACACTTCCGG-
CACGTAGT/RpS17-Probe: FAM-AGGAGGAAC GTGAGCGC
AGAGACA-IowaBlackFQ).
(h) Wolbachia density assessment in DENV-1 infected
females
Wolbachia density was measured in the extracted DNA from the
mosquito carcasses following the dissection of salivary glands
and midguts by multiplex qPCR. A mastermix consisting of
2 µl of extracted DNA, 5 µl of PrimeTime Gene Expression
Master Mix 2x, 0.375 µl of individual primer sets and 2 µl of






GCTGTTAGCCCT-IowaBlackFQ). PCRs were performed on a
LightCycler 480II system (Roche, Germany).
(i) Data analysis
All statistical analyses were conducted in the R software v. 3.2.3.
Viral titre andWolbachia density data were analysed with linear
models after log10 transformation to meet the assumptions of
normality and homoscedasticity. Post hoc pairwise comparisons
were performed with the function glht using a correction for
multiple testing (R package multcomp [43]).
Data accessibility. All raw data have been deposited in the University of
Glasgow data repository, link http://dx.doi.org/10.5525/gla.
researchdata.1044.
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